After watching his father suffer through unsuccessful treatment for Acute Myeloid Leukemia in 2002, Duncan enrolled in the biochemistry department of the UM graduate school. After a full biochemistry and immunology education he received his Ph.D. in Immunology from the University of Miami in the lab of Professor Robert Levy Ph.D. in the study of hematopoietic stem cell transplantation for hematologic disorders and the suppression of graft vs. host disease in 2012. Dr. Ross investigated various methods of immune suppression, from regulatory T cells to post transplant cyclophosphamide in collaboration with the Leo Luznik transplant lab at Johns Hopkins University in Baltimore, a collaboration from which multiple publications in the peer-reviewed journals Blood and the Biology of Blood and Marrow Transplantation 1,2 resulted. Duncan's interest in the use of mesenchymal stem cells (MSC) for immune suppression stemmed from this work and the work of others in the use of MSC to treat GVHD. Kimera Labs is now focused on the use of MSC for the suppression of various immune mediated pathologies and regenerative medicine in the US, Latin America, and the Bahamas.
Email: Duncanross@kimeralabs.com Curriculum Vitae
Dr. Ross was interviewed regarding stem cell therapies by the foremost video journalist in Colombia, Mr. Yamid Amat.
Response from the interview was overwhelming, with over 500 patients contacting Dr. Ross and the station.
CONTACT US: 1.844.707.2673
Latin America Patient Relations
Bogota: +57 1 3 81 90 36